AlphaCore Capital’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.14M Buy
14,567
+1,427
+11% +$569K 0.1% 174
2026
Q2
$4.76M Sell
13,140
-3,702
-22% -$1.27M 0.09% 194
2026
Q1
$5.93M Buy
16,842
+2,203
+15% +$785K 0.14% 131
2025
Q4
$4.79M Buy
14,639
+4,818
+49% +$1.53M 0.11% 167
2025
Q3
$2.77M Sell
9,821
-1,547
-14% -$449K 0.09% 167
2025
Q2
$3.17M Buy
11,368
+2,633
+30% +$746K 0.12% 133
2025
Q1
$2.72M Buy
8,735
+4,534
+108% +$1.34M 0.23% 92
2024
Q4
$1.09M Buy
4,201
+195
+5% +$57.9K 0.24% 72
2024
Q3
$1.29M Buy
4,006
+470
+13% +$154K 0.29% 63
2024
Q2
$1.1M Buy
3,536
+2,471
+232% +$726K 0.27% 65
2024
Q1
$303K Buy
+1,065
New +$312K 0.08% 126
2020
Q2
– Sell
-45
Closed -$9K – 82
2020
Q1
$9K Buy
+45
New +$9.8K 0.01% 220

Other funds holding AMGN

AlphaCore Capital's AMGN Position: Q3 2026 in Review

AlphaCore Capital increased its Amgen (AMGN) stake by 11% in Q3 2026, buying an estimated $569K and bringing the position to 14,567 shares worth $6.14M. The position accounts for 0.1% of the portfolio, ranked #174.

AlphaCore Capital first reported a position in AMGN in Q1 2020 and has held it in 12 quarters since. 2,162 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • AlphaCore Capital held 14,567 shares of Amgen worth $6.14M as of Q3 2026.
  • AlphaCore Capital bought 1,427 Amgen shares in Q3 2026, an estimated $569K.
  • Amgen made up 0.1% of AlphaCore Capital's portfolio in Q3 2026, its #174 holding.
  • AlphaCore Capital first reported a position in Amgen in Q1 2020 and has held it in 12 quarters since.
  • 2,162 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.